ATE67313T1 - Nachweis von menschlichem cytomegalovirusspezifischem igm. - Google Patents

Nachweis von menschlichem cytomegalovirusspezifischem igm.

Info

Publication number
ATE67313T1
ATE67313T1 AT85301058T AT85301058T ATE67313T1 AT E67313 T1 ATE67313 T1 AT E67313T1 AT 85301058 T AT85301058 T AT 85301058T AT 85301058 T AT85301058 T AT 85301058T AT E67313 T1 ATE67313 T1 AT E67313T1
Authority
AT
Austria
Prior art keywords
hcmv
detection
support
specific igm
monoclonal antibody
Prior art date
Application number
AT85301058T
Other languages
English (en)
Inventor
William Joseph Harris
Helena Frantiska Hart
Original Assignee
Cogent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cogent Ltd filed Critical Cogent Ltd
Application granted granted Critical
Publication of ATE67313T1 publication Critical patent/ATE67313T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/969—Multiple layering of reactants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Geophysics And Detection Of Objects (AREA)
AT85301058T 1984-02-20 1985-02-18 Nachweis von menschlichem cytomegalovirusspezifischem igm. ATE67313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404368A GB8404368D0 (en) 1984-02-20 1984-02-20 Monoclonal antibodies to human cytomegalovirus
EP85301058A EP0162533B1 (de) 1984-02-20 1985-02-18 Nachweis von menschlichem Cytomegalovirus-spezifischem IgM

Publications (1)

Publication Number Publication Date
ATE67313T1 true ATE67313T1 (de) 1991-09-15

Family

ID=10556863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85301058T ATE67313T1 (de) 1984-02-20 1985-02-18 Nachweis von menschlichem cytomegalovirusspezifischem igm.

Country Status (6)

Country Link
US (1) US4716104A (de)
EP (1) EP0162533B1 (de)
JP (1) JPH0614053B2 (de)
AT (1) ATE67313T1 (de)
DE (1) DE3584035D1 (de)
GB (2) GB8404368D0 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783399A (en) * 1984-05-04 1988-11-08 Scripps Clinic And Research Foundation Diagnostic system for the detection of cytomegalovirus
US4818678A (en) * 1984-05-04 1989-04-04 Scripps Clinic And Research Foundation Diagnostic system for the detection of cytomegalovirus
US6133433A (en) * 1984-07-27 2000-10-17 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6242567B1 (en) 1984-07-27 2001-06-05 City Of Hope Method for detection and prevention of human cytomegalovirus infection
ATE110084T1 (de) * 1985-12-06 1994-09-15 Teijin Ltd Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
EP0252531B1 (de) * 1986-06-12 1992-12-02 BEHRINGWERKE Aktiengesellschaft Strukturelles Phosphoprotein (pp 150) des menschlichen Cytomegalovirus, seine Herstellung und Verwendung
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
FR2611912B1 (fr) * 1987-03-03 1989-07-13 Biosys Sa Procede de detection et de denombrement d'antigenes particulaires dans un echantillon liquide, notamment des spores de clostridium tyrobutyricum dans le lait
EP0376973A1 (de) * 1987-08-07 1990-07-11 The Children's Hospital, Incorporated Monoklonale antikörper mit gegenwirkung auf glycoprotein a von cytomegalovirus
US5030555A (en) * 1988-09-12 1991-07-09 University Of Florida Membrane-strip reagent serodiagnostic apparatus and method
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
WO1991004277A1 (en) * 1989-09-14 1991-04-04 Children's Biomedical Research Institute Monoclonal antibodies specific to cytomegalovirus glycoprotein
US5750106A (en) * 1993-01-28 1998-05-12 Novartis Ag Human monoclonal antibodies to cytomegalovirus
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US6835383B2 (en) * 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
EP3009449B1 (de) 2008-07-16 2018-06-06 Institute for Research in Biomedicine Das humane cytomegalovirus neutralisierende antikörper und deren anwendung
PH12012501308A1 (en) 2009-12-23 2013-01-21 4 Antibody Ag Binding members for human cytomegalovirus
CN109082413B (zh) * 2018-09-18 2023-01-10 四川安可瑞新材料技术有限公司 抗人IgG单克隆抗体、其杂交瘤细胞株及应用
CN113788892B (zh) * 2021-11-16 2022-02-18 南京黎明生物制品有限公司 一种应用抗单纯疱疹病毒单克隆抗体的快速检测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US4407943A (en) * 1976-12-16 1983-10-04 Millipore Corporation Immobilized antibody or antigen for immunoassay
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4313927A (en) * 1979-10-19 1982-02-02 Ames-Yissum Ltd. Immunoassay method for detecting viral antibodies in whole blood samples
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
EP0060123B1 (de) * 1981-03-07 1986-10-29 Colin Henry Self Test und seine Verwendung
EP0084531B1 (de) * 1981-07-31 1987-05-20 Mount Sinai School Of Medicine Of The City University Of New York Test für viren
FR2519650B1 (fr) * 1982-01-13 1985-07-12 Univ Paris Curie Lignees cellulaires hybrides murines anti-herpes, procede d'obtention, anticorps monoclonaux anti-herpes, applications biologiques
FR2543570B1 (fr) * 1983-03-31 1985-08-09 Pasteur Institut Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains

Also Published As

Publication number Publication date
JPH0614053B2 (ja) 1994-02-23
JPS60252498A (ja) 1985-12-13
DE3584035D1 (de) 1991-10-17
US4716104A (en) 1987-12-29
GB8404368D0 (en) 1984-03-28
EP0162533A3 (en) 1987-08-19
GB2154609B (en) 1988-06-08
EP0162533A2 (de) 1985-11-27
EP0162533B1 (de) 1991-09-11
GB8504104D0 (en) 1985-03-20
GB2154609A (en) 1985-09-11

Similar Documents

Publication Publication Date Title
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
AU600466B2 (en) Htlv-iii envelope peptides
ES2082775T3 (es) Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
IT1177121B (it) Metodo per determinare i complessi immuni nel siero
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DE3585075D1 (de) Diagnosesystem zum nachweis von cytomegalovirus.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
DE3672624D1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
EP0248147A3 (de) Verfahren zur Bestimmung der Anwesenheit von Krebszellen
ES8106834A1 (es) Un metodo de producir un antisuero que tiene una mejor cua- lidad aglutinante
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection
FI870500A7 (fi) Reagenssi virus-antigeenin vasta-aineen määrittämiseksi.
FI914924A7 (fi) Monoklonaalinen vasta-aine suomusolukarsinooma-antigeenien erottamisee n ja menetelmä sen käyttämiseksi
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee